Navigation Links
Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
Date:11/10/2008

on the 2007 NCCN guidelines received a recommendation for hormone therapy alone based on their Oncotype DX Recurrence Score of less than 18. Conversely, and notably, four patients who would have received a recommendation against chemotherapy based on the 2007 NCCN guidelines were placed in the high-risk group based on their Recurrence Score of greater than 31 and received a recommendation for chemotherapy.

"As more physicians incorporate Oncotype DX into clinical practice, we gain important insight into its impact on the treatment decision process for physicians and patients," said Steven Shak, M.D., chief medical officer of Genomic Health. "There are now seven studies, conducted by independent physicians who use the test in clinical practice, demonstrating that Oncotype DX optimizes the use of chemotherapy to ensure those women who need chemotherapy get it, while sparing those who are not likely to benefit from its side effects and high costs."

About Oncotype DX(R)

Oncotype DX is the first and only multi-gene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. Additionally, the test report provides quantitative scores for certain individual genes. Oncotype DX has been extensively evaluated in eleven clinical studies involving nearly 4,000 breast cancer patients, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. To date, 7,500 physicians have ordered more than 75,000 tests, and both Medicare and private health plans covering approximately 90 percent of U.S. insured lives provide reimbursement for Oncotype DX through contracts, agreements and policy decisions. Both the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network recommend the use of Oncotype DX for pa
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
2. Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference
3. /C O R R E C T I O N -- Rosetta Genomics Ltd/
4. Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
5. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
6. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
7. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
8. Transgenomic, Inc. Reports Third Quarter 2008 Results
9. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
10. Genomic Health to Announce Third Quarter 2008 Financial Results and Host Conference Call on Wednesday, November 5, 2008
11. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Health Enhancement Products, Inc. (OTCQB: ... early-stage algae bioactive compounds and metabolic processes, is pleased to ... board of directors. Ms. Nola E. Masterson , a ... joined the board effective September 17, 2014. ... to join our board," states Andrew Dahl , President ...
(Date:9/18/2014)... Research and Markets has ... Industry Report 2014" report to their offering. ... 2014 is a professional and in-depth study on ... The report provides a basic overview ... industry chain structure. The N-acetylcysteine market analysis is ...
(Date:9/18/2014)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... NewsMakers in the Biotech Industry conference on Friday, September ... Broadway Hotel & Conference Center in New York ... accessed at www.meipharma.com . A replay will be available ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 OMICS ... the globe to participate in the ‘Open Access ... articles to OMICS Group Pharma Journals ... one of the fastest emerging Sciences, accelerating with ... healthcare services across the globe. The industry is ...
Breaking Biology Technology:Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global N-acetylcysteine Industry Report 2014 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3
... - In order to enhance the worldwide launch of ... has formed a strategic marketing alliance with the globally operating ... food proof® range which has been available in almost ... new products will be launched jointly during the year 2008. ...
... VANCOUVER, April 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... global specialty pharmaceutical and,medical device company, today ... "BSC" (NYSE: BSX ) has received ... paclitaxel-eluting coronary stent system in Canada.,BSC reported ...
... 18 Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) ... letter from The NASDAQ Stock Market indicating that for ... its common stock has closed,below the minimum $1.00 per ... notification has no immediate effect on,the listing of or ...
Cached Biology Technology:BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 2BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance 3Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 2Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 3Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 4Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement 2
(Date:9/18/2014)... researchers and their colleagues have built the first ... academic performance and behavioral trends. In other words, ... even if you don,t -- and how that ... students, happiness, stress, depression and loneliness to their ... general population for example, to monitor mental ...
(Date:9/18/2014)... algal forests in the eastern Mediterranean Sea pose a ... distribution continues to expand as the climate warms, a ... of researchers led by Dr Adriana Vergs of UNSW ... for Advanced Studies in Spain, is published in the ... surveyed more than 1000 kilometres of coastline in Turkey ...
(Date:9/18/2014)... camouflage: you don,t just blend in, the background shows ... as you might think. Kathryn Feller, from the University ... life stages of many marine species are transparent. However, ... creatures cannot make transparent. Feller explains that the animals ... unit with an opaque pigment to prevent light leaking ...
Breaking Biology News(10 mins):New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Tropical fish a threat to Mediterranean Sea ecosystems 2Transparent larvae hide opaque eyes behind reflections 2
... substance found in red grapes and red wine, may have ... to a published laboratory study from Henry Ford Hospital in ... likely to suffer the long-term effects of noise-induced hearing loss ... a long period of time. "Our latest study focuses ...
... to become knotted, thus it may be useful to disentangle ... at random (or better, in one solution) the filaments with ... solutions like, for instance, having the DNA pass through nano-pores ... may exploit to selectively let a type of molecule pass ...
... struggling to collect and analyze millions of gigabytes of ... National Institutes of Health has launched a $700 million ... training future scientists to tap that gold mine of ... current edition of Chemical & Engineering News ...
Cached Biology News:Study: Resveratrol shows promise to protect hearing, cognition 2The nano-channel that disentangles knots 2